{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Biosimilars & Biopharmaceuticals",
    "sector_kpis": {
      "kpi_1": "R&D Spend: 7% of Revenue",
      "kpi_2": "Core EBITDA Margin: 28%",
      "kpi_3": "Biosimilars Rev Growth: 25% YoY"
    },
    "moat_rating": "Narrow",
    "competitive_position": "LEADER"
  },
  "_cached_at": "2025-12-31T12:38:54.482426",
  "_symbol": "BIOCON"
}